Finance

Lists
Why is NAMS down 5.64%?
Dive Deeper
NAMS:NASDAQ
NewAmsterdam Pharma Company NV
US$18.41
-5.64%
(-1.10) 1D
US$18.32
-0.49% (-0.090)
After hours
Closed: ኖቬም 20, 4:00:01 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAMS...
Open
US$19.21
High
US$19.78
Low
US$18.28
Mkt. cap
2.21 ቢ
Avg. vol.
1.67 ሚ
Volume
1.75 ሚ
52-wk high
US$42.20
52-wk low
US$17.90
EPS
-US$1.68
Beta
0.14
Shares outstanding
119.93 ሚ
No. of employees
100
Open
US$19.21
High
US$19.78
Low
US$18.28
Mkt. cap
2.21 ቢ
Avg. vol.
1.67 ሚ
Volume
1.75 ሚ
52-wk high
US$42.20
52-wk low
US$17.90
EPS
-US$1.68
Beta
0.14
Shares outstanding
119.93 ሚ
No. of employees
100
News stories
From web sources and news partners
About NewAmsterdam Pharma Company NV
CEO-
Employees100
Founded2019
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 11 analysts giving stock ratings to NAMS in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for NAMS in the last 3 months.
Highest
Current US$18.41
US$61.00 (+231.34%)
Average
US$54.70 (+197.12%)
Lowest
US$42.00 (+128.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
US$61.00
+231.3%
11/10/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
US$50.00
+171.6%
11/09/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$60.00
+225.9%
11/09/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$52.00
+182.5%
11/06/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
US$57.00
+209.6%
11/05/2026
Conor MacKay
BMO Capital
Buy
Maintained
US$58.00
+215%
11/05/2026
Leonid Timashev
RBC Capital
Buy
Reiterated
US$42.00
+128.1%
11/04/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
US$55.00
+198.8%
11/05/2026
Geoff Meacham
Citi
Buy
Maintained
US$55.00
+198.8%
10/15/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
US$57.00
+209.6%
09/22/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
09/18/2026
Serge Belanger
Needham
Buy
Maintained
US$48.00
+160.7%
08/07/2026
Unknown Analyst
Citi
Buy
Maintained
US$55.00
+198.8%
08/06/2026
Evan Seigerman
BMO Capital
Buy
Initiated
US$58.00
+215%
07/21/2026
Unknown Analyst
BMO Capital
Buy
Initiated
US$58.00
+215%
07/20/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
US$45.00
+144.4%
05/07/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/07/2026
Asad Haider
Goldman Sachs
Hold
Maintained
US$38.00
+106.4%
05/07/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
US$45.00
+144.4%
04/02/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
32.00 ሺ
3.04 ሚ
3.70 ሚ
19.16 ሚ
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
38.59 ሚ
38.01 ሚ
41.67 ሚ
39.36 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.42 ሚ
23.45 ሚ
26.89 ሚ
24.00 ሚ
Operating expense
66.01 ሚ
61.46 ሚ
68.56 ሚ
63.35 ሚ
Total operating expenses
66.01 ሚ
61.46 ሚ
68.56 ሚ
63.35 ሚ
Operating income
-65.98 ሚ
-58.42 ሚ
-64.86 ሚ
-44.19 ሚ
Other non operating income
-15.34 ሚ
5.94 ሚ
-4.56 ሚ
23.12 ሚ
EBT including unusual items
-74.92 ሚ
-48.44 ሚ
-64.14 ሚ
-16.18 ሚ
EBT excluding unusual items
-74.92 ሚ
-48.44 ሚ
-64.14 ሚ
-16.18 ሚ
Income tax expense
-
-
-
1.21 ሚ
Effective tax rate
-
-
-
-7.46%
Other operating expenses
-
-
-
-
Net income
-74.92 ሚ
-48.44 ሚ
-64.14 ሚ
-17.39 ሚ
Net profit margin
-234,134.38%
-1,593.45%
-1,732.91%
-90.74%
Earnings per share
-
-
-
-
Interest and investment income
6.47 ሚ
5.65 ሚ
5.81 ሚ
5.19 ሚ
Interest expense
-
-
-
-
Net interest expenses
6.47 ሚ
5.65 ሚ
5.81 ሚ
5.19 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
-65.92 ሚ
-58.36 ሚ
-64.80 ሚ
-44.12 ሚ
Gain or loss from assets sale
11.00 ሺ
12.00 ሺ
6.00 ሺ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች